Neurocrine Biosciences Inc (NBIX)
133.30
+0.30
(+0.23%)
USD |
NASDAQ |
Apr 17, 16:00
133.30
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Market Cap: 13.26B for April 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 16, 2024 | 13.23B |
| April 15, 2024 | 13.11B |
| April 12, 2024 | 13.40B |
| April 11, 2024 | 13.53B |
| April 10, 2024 | 13.74B |
| April 09, 2024 | 13.83B |
| April 08, 2024 | 13.88B |
| April 05, 2024 | 13.82B |
| April 04, 2024 | 13.69B |
| April 03, 2024 | 13.69B |
| April 02, 2024 | 13.71B |
| April 01, 2024 | 14.07B |
| March 28, 2024 | 13.72B |
| March 27, 2024 | 13.72B |
| March 26, 2024 | 14.05B |
| March 25, 2024 | 13.96B |
| March 22, 2024 | 14.07B |
| March 21, 2024 | 14.30B |
| March 20, 2024 | 14.00B |
| March 19, 2024 | 14.02B |
| March 18, 2024 | 13.88B |
| March 15, 2024 | 13.84B |
| March 14, 2024 | 13.85B |
| March 13, 2024 | 14.11B |
| March 12, 2024 | 13.71B |
| Date | Value |
|---|---|
| March 11, 2024 | 13.79B |
| March 08, 2024 | 13.85B |
| March 07, 2024 | 13.47B |
| March 06, 2024 | 13.16B |
| March 05, 2024 | 13.30B |
| March 04, 2024 | 13.25B |
| March 01, 2024 | 13.07B |
| February 29, 2024 | 12.98B |
| February 28, 2024 | 13.40B |
| February 27, 2024 | 13.54B |
| February 26, 2024 | 13.49B |
| February 23, 2024 | 13.35B |
| February 22, 2024 | 13.27B |
| February 21, 2024 | 13.00B |
| February 20, 2024 | 13.20B |
| February 16, 2024 | 13.17B |
| February 15, 2024 | 13.33B |
| February 14, 2024 | 13.11B |
| February 13, 2024 | 13.32B |
| February 12, 2024 | 12.98B |
| February 09, 2024 | 13.16B |
| February 08, 2024 | 13.38B |
| February 07, 2024 | 13.56B |
| February 06, 2024 | 14.23B |
| February 05, 2024 | 14.10B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.595B
Minimum
Apr 30 2019
14.30B
Maximum
Mar 21 2024
9.750B
Average
9.428B
Median
Market Cap Benchmarks
| Baxter International Inc | 20.08B |
| Azenta Inc | 2.853B |
| Hologic Inc | 17.59B |
| West Pharmaceutical Services Inc | 27.63B |
| Globus Medical Inc | 6.932B |
Market Cap Related Metrics
| PE Ratio | 55.08 |
| PS Ratio | 7.074 |
| PEG Ratio | 0.9469 |
| Price to Book Value | 5.943 |
| Price to Free Cash Flow | 36.92 |
| Price | 133.30 |
| Earnings Yield | 1.82% |
| PEGY Ratio | 0.9469 |
| Operating PE Ratio | 33.81 |
| Normalized PE Ratio | 46.64 |